OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
39
Results
Show all
Save search
Copy query
Show results for
Unknown
(39)
Publication Date
Release Date
2022
(7)
2016
(6)
2021
(4)
2020
(4)
2026
(3)
2025
(3)
2023
(3)
2024
(2)
2019
(2)
2018
(2)
2014
(2)
2015
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study.
Not available
S-EPMC5844668
|
biostudies-literature
Cite
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.
Not available
S-EPMC12896398
|
biostudies-literature
Cite
Trematode infection affects shell shape and size in
Bulinus tropicus
.
Not available
S-EPMC9357703
|
biostudies-literature
Cite
Prevalence of Endemic Respiratory Viruses During the COVID-19 Pandemic in Urban and Rural Malawi.
Not available
S-EPMC10836885
|
biostudies-literature
Cite
Association of cancer incidence and randomized trial evidence for FDA approval of new cancer drugs.
Not available
S-EPMC12780758
|
biostudies-literature
Cite
The role of additional radiotherapy for primary central nervous system lymphoma.
Not available
S-EPMC6524751
|
biostudies-literature
Cite
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.
Not available
S-EPMC12862307
|
biostudies-literature
Cite
The role of whole brain radiation in primary CNS lymphoma.
Not available
S-EPMC4968379
|
biostudies-literature
Cite
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Not available
S-EPMC4839072
|
biostudies-literature
Cite
Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK).
Not available
S-EPMC10124283
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets